PureTech Health plc (PRTC)

PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of $408.30 million. The enterprise value is $175.04 million.

Market Cap	408.30M
Enterprise Value	175.04M

Important Dates

The last earnings date was Wednesday, April 30, 2025, before market open.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

PureTech Health has 239.42 million shares outstanding. The number of shares has decreased by -7.34% in one year.

Current Share Class	n/a
Shares Outstanding	239.42M
Shares Change (YoY)	-7.34%
Shares Change (QoQ)	-10.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	160.18M

Valuation Ratios

The trailing PE ratio is 7.63.

PE Ratio	7.63
Forward PE	n/a
PS Ratio	84.57
Forward PS	n/a
PB Ratio	1.00
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	3.27
EV / Sales	36.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.41.

Current Ratio	9.33
Quick Ratio	9.19
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.54

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is -14.55%.

Return on Equity (ROE)	6.41%
Return on Assets (ROA)	-13.10%
Return on Invested Capital (ROIC)	-14.55%
Return on Capital Employed (ROCE)	-24.21%
Revenue Per Employee	$60,350
Profits Per Employee	$668,875
Employee Count	80
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-4.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.15% in the last 52 weeks. The beta is 0.87, so PureTech Health's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-38.15%
50-Day Moving Average	17.24
200-Day Moving Average	19.58
Relative Strength Index (RSI)	51.72
Average Volume (20 Days)	2,098

Short Selling Information

Short Interest	10,349
Short Previous Month	10,931
Short % of Shares Out	0.06%
Short % of Float	n/a
Short Ratio (days to cover)	1.00

Income Statement

In the last 12 months, PureTech Health had revenue of $4.83 million and earned $53.51 million in profits. Earnings per share was $0.21.

Revenue	4.83M
Gross Profit	-64.40M
Operating Income	-135.87M
Pretax Income	-35.17M
Net Income	53.51M
EBITDA	-134.06M
EBIT	-135.87M
Earnings Per Share (EPS)	$0.21

Balance Sheet

The company has $378.69 million in cash and $165.58 million in debt, giving a net cash position of $213.11 million or $0.89 per share.

Cash & Cash Equivalents	378.69M
Total Debt	165.58M
Net Cash	213.11M
Net Cash Per Share	$0.89
Equity (Book Value)	407.93M
Book Value Per Share	1.73
Working Capital	344.87M

Cash Flow

In the last 12 months, operating cash flow was -$134.37 million and capital expenditures -$11,000, giving a free cash flow of -$134.38 million.

Operating Cash Flow	-134.37M
Capital Expenditures	-11,000
Free Cash Flow	-134.38M
FCF Per Share	-$0.56

Margins

Gross Margin	n/a
Operating Margin	-2,814.19%
Pretax Margin	492.42%
Profit Margin	1,108.33%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	7.34%
Shareholder Yield	7.34%
Earnings Yield	13.11%
FCF Yield	-32.91%

Analyst Forecast

The average price target for PureTech Health is $45.00, which is 164.40% higher than the current price. The consensus rating is "Buy".

Price Target	$45.00
Price Target Difference	164.40%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PureTech Health has an Altman Z-Score of 1.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.88
Piotroski F-Score	4